{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:03:46Z","timestamp":1791849826574,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":4114,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1111\/j.1523-1755.2004.09004.x","type":"journal-article","created":{"date-parts":[[2004,8,6]],"date-time":"2004-08-06T09:49:56Z","timestamp":1091785796000},"page":"S8-S12","source":"Crossref","is-referenced-by-count":67,"special_numbering":"S90","title":["Consequences of hyperphosphatemia in patients with end-stage renal disease (ESRD)"],"prefix":"10.1016","volume":"66","author":[{"given":"Wajeh Y.","family":"Qunibi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0010","series-title":"USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2003"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1111\/j.1523-1755.2004.09004.x_bb0020","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"NATIONAL KIDNEY FOUNDATION","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"10.1111\/j.1523-1755.2004.09004.x_bb0025","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1053\/ajkd.2001.20740","article-title":"Role of phosphorus in the pathogenesis of secondary hyperparathyroidism","volume":"37","author":"Slatopolsky","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0030","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1523-1755.2001.059003855.x","article-title":"p21 (WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth","volume":"59","author":"Dusso","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0035","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJM199507203330307","article-title":"Mechanisms of disease: Renal osteodystrophy","volume":"333","author":"Hruska","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0040","first-page":"F432","article-title":"Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol","volume":"259","author":"LOPEZ-HILKER","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0045","first-page":"7","article-title":"1,25 dihydroxycholecalciferol and parathyroid hormone in advanced renal failure: Effects of simultaneous protein and phosphorus restriction","volume":"25","author":"Lucas","year":"1986","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0050","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid gland in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J Bone Miner Res"},{"issue":"Suppl 73","key":"10.1111\/j.1523-1755.2004.09004.x_bb0060","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"56","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0065","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1046\/j.1523-1755.2001.00042.x","article-title":"p21WAF1 and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium","volume":"60","author":"Cozzolino","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0070","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1681\/ASN.V133693","article-title":"Regulation of arachidonic acid production by intracellular calcium in parathyroid cells: Effect of extracellular phosphate","volume":"13","author":"Almaden","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1525-139X.1999.00006.x","article-title":"Epidemiology of cardiac disease in dialysis patients","volume":"12","author":"Sarnak","year":"1999","journal-title":"Semin Dial"},{"issue":"Suppl 3","key":"10.1111\/j.1523-1755.2004.09004.x_bb0080","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","article-title":"Clinical epidemiology of cardiovascular disease in chronic renal disease","volume":"32","author":"Foley","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0085","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1093\/ndt\/14.9.2178","article-title":"Association of hyperphosphatemia with hemodynamic disturbances in end-stage renal disease","volume":"14","author":"Marchais","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0090","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/ndt\/17.10.1713","article-title":"Arterial structure and function in end-stage renal disease","volume":"17","author":"London","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0095","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1161\/01.CIR.103.11.1529","article-title":"Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality","volume":"103","author":"Wilson","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0100","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1523-1755.1999.00575.x","article-title":"Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure","volume":"56","author":"Rostand","year":"1999","journal-title":"Kidney Int"},{"issue":"Suppl 82","key":"10.1111\/j.1523-1755.2004.09004.x_bb0105","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1046\/j.1523-1755.62.s82.15.x","article-title":"Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenon","volume":"62","author":"Qunibi","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0002-9149(94)90223-2","article-title":"Detection of coronary artery calcium by ultrafast computed tomography and its relation to clinical evidence of coronary artery disease","volume":"73","author":"Wong","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0115","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/01.CIR.94.5.1175","article-title":"Coronary artery calcification: Pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association Writing Group","volume":"94","author":"Wexler","year":"1996","journal-title":"Circulation"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0120","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electronic beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0125","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0130","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO4, Ca x PO4 product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0135","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2004.09004.x_bb0140","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1053\/ajkd.2001.27394","article-title":"Vascular calcification and inorganic phosphate","volume":"38","author":"Giachelli","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0145","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1681\/ASN.V114778","article-title":"Calcification of the aortic valve in dialyzed patients","volume":"11","author":"London","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0150","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1093\/ndt\/13.8.2037","article-title":"Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism","volume":"12","author":"Ribeiro","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 85","key":"10.1111\/j.1523-1755.2004.09004.x_bb0155","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1046\/j.1523-1755.63.s85.27.x","article-title":"Heart valve calcification and calcium X phosphorus product in hemodialysis patients: Analysis of optimum values for its prevention","volume":"63","author":"Rufino","year":"2003","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/01.ASN.0000038685.95946.83","article-title":"Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: A prospective study","volume":"13","author":"Wang","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1111\/j.1523-1755.2004.09004.x_bb0165","first-page":"77","article-title":"Calcific uremic arteriolopathy: A new look at an old disorder","volume":"3","author":"Moe","year":"2004","journal-title":"Neph SAP"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0170","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1046\/j.1523-1755.2002.00375.x","article-title":"Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy","volume":"61","author":"Fine","year":"2002","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0175","first-page":"160","article-title":"Calcific uremic arteriolopathy in association with low turnover uremic bone disease","volume":"52","author":"Mawad","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0180","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","article-title":"Risk factors and mortality associated with calciphylaxis in end-stage renal disease","volume":"60","author":"Mazhar","year":"2001","journal-title":"Kidney Int"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0185","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","article-title":"Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells","volume":"37","author":"Ahmad","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0190","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/ajkd.1998.v32.pm9740152","article-title":"A case control study of proximal calciphylaxis","volume":"32","author":"Bleyer","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"10.1111\/j.1523-1755.2004.09004.x_bb0195","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","author":"NATIONAL KIDNEY FOUNDATION","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0200","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(12)70364-5","article-title":"Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities","volume":"15","author":"Lowrie","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1523-1755.2004.09004.x_bb0205","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0272-6386(00)70064-3","article-title":"Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management","volume":"35","author":"Block","year":"2000","journal-title":"Am J Kidney Dis"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815503712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815503712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T21:38:44Z","timestamp":1624570724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815503712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":40,"alternative-id":["S0085253815503712"],"URL":"https:\/\/doi.org\/10.1111\/j.1523-1755.2004.09004.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}